Radiopharmaceuticals have grabbed the drug industry’s attention, but in clinical trials, developers are seeing the problems with isotopes.
ITM Isotope Technologies Munich said the agency cited manufacturing issues in its letter rejecting the radiopharmaceutical treatment.
Today's biotech news includes China reining in its biotech engine, radiopharma meeting unexpected hurdles, and more
Silence's polycythemia vera drug, called divesiran, could compete with a Takeda drug nearing approval called rusfertide.
Play: What's the word? Test your knowledge with today's mini crossword
